Results 141 to 150 of about 7,483 (199)

Efficacy, immunogenicity, and safety of BCG revaccination against Mycobacterium tuberculosis: A systematic review and meta-analysis. [PDF]

Hum Vaccin Immunother
Ali SH, Shakir S, Shaikh UA, Shaikh UA, Khalid M, Jawed M, Ali SI, Samo M, Shariq H, Khan MS, Naeem U, Waafira A.   +11 more
europepmc   +1 more source

Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment. [PDF]

Front Immunol
Cheng J, Jiang Y, Chen Q, Xiao M.
europepmc   +1 more source

The Role of CD4⁺ T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy. [PDF]

Cells
Shao J, Na J, Huang H, Xiao L, Dang F, Zheng R, Zhong L, Zhao Y.   +7 more
europepmc   +1 more source

Why, Immunologically, Housing-Related Fungi and Endotoxins (and Other Chronic Pro-Inflammatory Stressors) Risk Latent Tuberculosis Reactivation, Severe Asthma, and Translocating and Invasive Infections in Indigenous Communities in Canada. [PDF]

Am J Hum Biol
Burke S.
europepmc   +1 more source

Skin Tape Stripping: A Non-Invasive Approach Linking Epidermal Changes and Systemic Inflammation in Atopic Dermatitis. [PDF]

Clin Transl Allergy
Tian Z, Xue K, Cui Y.
europepmc   +1 more source

Non-canonical IL‑22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillance. [PDF]

Nat Commun
Millet N, Sekar J, Solis NV, Miao J, Millet A, Aggor FEY, Wildeman A, Cook ME, Davari A, Peters BM, Lionakis MS, Gaffen SL, Jendzjowsky N, Filler SG, Swidergall M.   +14 more
europepmc   +1 more source

Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence. [PDF]

Front Immunol
Tian J, Ding J, You H, Ou C, Zhu H, Cheng B.   +5 more
europepmc   +1 more source

Molecular crosstalk between AHR, CYP1B1, and ITGAM in diabetic nephropathy: Integrated insights from bioinformatics and experimental validation. [PDF]

Biochem Biophys Rep
Hosseini SA, Ajorlou P, Mousavi P, Aghamirli S, Dehghani A.   +4 more
europepmc   +1 more source

Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]

Indian Dermatol Online J
Gupta A, Neema S.
europepmc   +1 more source

BPZE1 vaccination induces IL-17⁺ and IL-22⁺ CD4⁺ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation. [PDF]

NPJ Vaccines
Hill AR, Gbesemete DF, Coutinho T, Ibrahim M, Laver JR, Goldstein P, Noviello S, Rubin K, Faust SN, Locht C, Read RC, Dale AP.   +11 more
europepmc   +1 more source